Abstract

BackgroundAdiponectin (AD), produced prevalently by adipose tissues, has suggested playing a significant role in chronic inflammation and immune response. The relation between AD and rheumatoid arthritis (RA) has been a...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C
Ruiru Li ... Siqi Xu
Cell Death & Disease | VOL. 13
Ruiru Li, et. al.Ruiru Li ... Siqi Xu
13 Dec 2022
An herbal formula inhibits STAT3 signaling and attenuates bone erosion in collagen-induced arthritis rats
Wai-Chung Leung ... Zheng-Zhi Wu
Phytomedicine | VOL. 76
Wai-Chung Leung, et. al.Wai-Chung Leung ... Zheng-Zhi Wu
30 May 2020
Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis
Rui Liu ... Qin Wu
Arthritis Research & Therapy | VOL. 20
Rui Liu, et. al.Rui Liu ... Qin Wu
08 Feb 2018
Adiponectin exacerbates collagen-induced arthritis via enhancing Th17 response and prompting RANKL expression.
Xiaoke Feng ... Xiaoxuan Sun
Scientific reports | VOL. 5
Xiaoke Feng, et. al.Xiaoke Feng ... Xiaoxuan Sun
11 Jun 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers